Controlled release of tetracycline—III: A physiological pharmacokinetic model of the pregnant rat
- 1 December 1980
- journal article
- research article
- Published by Springer Nature in Journal of Pharmacokinetics and Biopharmaceutics
- Vol. 8 (6) , 599-620
- https://doi.org/10.1007/bf01060056
Abstract
A controlled tetracycline delivery device, consisting of a membrane enclosed trilaminate disc fabricated from a series of 2-hydroxyethylmethacrylate/methylmethacrylate copolymers, demonstrated the ability to deliver tetracycline at zero-order rates in vitro and in vivo in rats and was applied to study the pharmacokinetics of tetracycline in the pregnant rat. The trilaminate discs containing tetracycline were implanted in pregnant Sprague-Dawley rats on the eighth day of gestation. The animals were sacrificed on days 19, 20, and 21 of gestation in order to measure the distribution of the controlled release tetracycline in the maternal, fetal, and placental tissues. Constant plasma tetracycline levels were attained in both the maternal and fetal circulations after 4 to 5 days postimplantation of the trilaminate discs. Placental transfer of tetracycline appeared rapid and no partitioning of the drug was observed between the maternal and fetal plasma. Tetracycline levels did not differ significantly in the maternal and fetal soft tissues (liver, kidney, G. I. tract, muscle, placenta) as measured over the last 3 to 4 days of the animal's gestational period. Highest tetracycline concentrations were determined in the fetal bone samples. In addition, some accumulation of the drug occurred in the amniotic fluid. A flow-limited pharmacokinetic model was constructed to simulate the distribution of tetracycline, delivered at a constant rate from the trilaminate device, in the pregnant rats. Predictions of fetal growth and maternal and fetal tissue tetracycline concentrations were in good agreement with the experimental measurements. The ability of these copolymer systems to deliver tetracycline at zero-order rates over extended periods offers numerous potential therapeutic and investigational applications, especially where such drug delivery characteristics are beneficial to the elucidation of physiological rate mechanisms, as in the pregnant animal.Keywords
This publication has 29 references indexed in Scilit:
- Controlled Release of Tetracycline II: Development of an In Vivo Flow-Limited Pharmacokinetic ModelJournal of Pharmaceutical Sciences, 1979
- Controlled Release of Tetracycline I: In Vitro Studies with a Trilaminate 2-Hydroxyethyl Methacrylate-Methyl Methacrylate SystemJournal of Pharmaceutical Sciences, 1979
- A review of the applications of physiologically based pharmacokinetic modelingJournal of Pharmacokinetics and Biopharmaceutics, 1979
- Drug Kinetics in PregnancyClinical Pharmacokinetics, 1977
- Embryonic and postnatal growth of rat and mouseCells Tissues Organs, 1976
- Enterohepatic Circulation of Tetracycline in RatsJournal of Pharmaceutical Sciences, 1975
- Recovery and determination of 3H-tetracycline from whole bonesBiochemical Medicine, 1973
- ETIOLOGY OF CATARACTS IN CHILDHOODThe Lancet, 1965
- Fatty liver of pregnancy and its relationship to tetracycline therapyThe American Journal of Medicine, 1965
- DISCOLORATION OF PRIMARY DENTITION AFTER MATERNAL TETRACYCLINE INGESTION IN PREGNANCYThe Lancet, 1964